American Journal of Preventive Medicine
Volume 38, Issue 6 , Pages 600-609, June 2010

Deaths Preventable in the U.S. by Improvements in Use of Clinical Preventive Services

  • Thomas A. Farley, MD, MPH

      Affiliations

    • New York City Department of Health and Mental Hygiene, New York, New York
    • Corresponding Author InformationAddress correspondence to: Thomas A. Farley, MD, MPH, New York City Department of Health and Mental Hygiene, 125 Worth Street, CN-28, New York NY 10013
  • ,
  • Mehul A. Dalal, MD, MSc, MHS

      Affiliations

    • New York City Department of Health and Mental Hygiene, New York, New York
  • ,
  • Farzad Mostashari, MD, MPH

      Affiliations

    • Office of the National Coordinator for Health Information Technology, USDHHS, Washington, Washington
  • ,
  • Thomas R. Frieden, MD, MPH

      Affiliations

    • CDC, Atlanta, Georgia

Background

Healthcare reform plans refer to improved quality, but there is little quantification of potential health benefits of quality care.

Purpose

This paper aims to estimate the health benefits by greater use of clinical preventive services.

Methods

Two mathematical models were developed to estimate the number of deaths potentially prevented per year by increasing use of nine clinical preventive services. One model estimated preventable deaths from all causes, and the other estimated preventable deaths from specific categories of causes. Models were based on estimates of the prevalence of risk factors for which interventions are recommended, the effect of those risk factors on mortality, the effect of the interventions on mortality in those at risk, and current and achievable rates of utilization of the interventions.

Results

Both models predicted substantial numbers of deaths prevented by greater use of the preventive services, with the greatest increases from services that prevent cardiovascular disease. For example, the all-cause model predicted that every 10% increase in hypertension treatment would lead to an additional 14,000 deaths prevented and every 10% increase in treatment of elevated low-density lipoprotein cholesterol or aspirin prophylaxis would lead to 8000 deaths prevented in those aged <80 years, per year. Overall, the models suggest that optimal use of all of these interventions could prevent 50,000–100,000 deaths per year in those aged <80 years and 25,000–40,000 deaths per year in those aged <65 years.

Conclusions

Substantial improvements in population health are achievable through greater use of a small number of preventive services. Healthcare systems should maximize use of these services.

 

 Thomas A. Farley was an employee of the Department of Community Health Sciences, Tulane University School of Public Health and Tropical Medicine, when this research was completed.

 Mehul A. Dalal was an employee of the Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine, when this research was completed.

 Farzad Mostashari and Thomas R. Frieden were employees of the New York City Department of Health and Mental Hygiene when this research was completed.

PII: S0749-3797(10)00207-2

doi:10.1016/j.amepre.2010.02.016

American Journal of Preventive Medicine
Volume 38, Issue 6 , Pages 600-609, June 2010